• Therapeutic Cataract & Refractive
  • Lens Technology
  • Glasses
  • Ptosis
  • AMD
  • COVID-19
  • DME
  • Ocular Surface Disease
  • Optic Relief
  • Geographic Atrophy
  • Cornea
  • Conjunctivitis
  • Myopia
  • Presbyopia
  • Allergy
  • Nutrition
  • Pediatrics
  • Retina
  • Cataract
  • Contact Lenses
  • Lid and Lash
  • Dry Eye
  • Glaucoma
  • Refractive Surgery
  • Comanagement
  • Blepharitis
  • OCT
  • Patient Care
  • Diabetic Eye Disease
  • Technology

Video point-counterpoint: Social media vs. web site


Watch Dr. Justin Bazan and Jason Daniels debate the merits of a practice Web site or a practice social media presence

Authors of the May Optometry Times Point-Counterpoint piece take their discussion to video.

Private practitioner Justin Bazan, OD, of Brooklyn, and Jason Daniels, director of sales at EyeCarePro, share their reasons on why social media or Web sites are the best digital presence for optometrists.

“I found a better way to attract new patients and engage with current patients with Facebook,” says Dr. Bazan.

Says Daniels: “Almost everybody uses Google to find products and services. Not having a Web site is going to create a lapse in the number of people who will come into that practice.”

Continue the conversation by watching their interaction and letting us know where you stand. 

Related Videos
Andy Morgenstern, OD, FAAO, FNAP chats with Optometry Times
R Tracy Williams, OD, FAAO with Optometry Times
Shan Lin, MD, speaks on Glaucoma 360 presentation in an interview with Ophthalmology Times
Cecelia Koetting, OD, FAAO, DIPABO, left, speaks with Optometry Times about the 2024 EnVision Summit
Bonnie An Henderson, MD, highlights key takeaways of the 2024 EnVision Summit, including diversity and family inclusion
Danica Marrelli, OD, FAAO, AAO Dipl, co-chair of EnVision Summit chats about geographic atrophy and glaucoma panels
Robert Weiss, former CEO and President of The Cooper Companies, Inc. (left) and Optometry Times' Assistant Managing Editor Emily Kaiser Maharjan Image Credit ©Optometry Times
© 2024 MJH Life Sciences

All rights reserved.